|3Apr 6, 4:11 PM ET

GENZYME CORP 3

3 · GENZYME CORP · Filed Apr 6, 2011

Insider Transaction Report

Form 3
Period: 2011-04-05
Holdings
  • Common Stock, $0.01 par value

    (indirect: By GC Merger Corp.)
    184,038,545
Footnotes (2)
  • [F1]Reflects shares exchanged in an exchange offer.
  • [F2]The shares are held by GC Merger Corp. (the "Purchaser"). The Purchaser is direct wholly-owned subsidiary of sanofi-aventis ("Parent") and is the owner of the shares purchased in the exchange offer. The shares may also be deemed to be indirectly beneficially owned by Parent.

Documents

2 files